✨ Free AI Report
Medacta Group SA: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Medacta Group SA
Company Research

Medacta Group SA: Business Overview, Financials & Competitive Analysis

Medacta Group is a Swiss-based medical device company specializing in orthopedic and neurosurgical solutions. The company designs, manufactures, and distributes innovative products and personalized 3D planning tools f...

Analyst-debate audio for Medacta Group SA

AskCyborg analysts argue the bull and bear cases for Medacta Group SA across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
7/ 10Strong

Cyborg Score thesis

Well-positioned Swiss medtech company with differentiated 3D planning technology, strong organic growth, and strategic M&A...

Read the full analyst-debate transcript →
Industry Orthopedic and Neurosurgical Medical Devices
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: October 19, 2026
AI-Generated Research
30+ Page Report

Get the Latest Medacta Group SA Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Medacta Group SA Overview

Pro stress-test →

Medacta Group is a Swiss-based medical device company specializing in orthopedic and neurosurgical solutions. The company designs, manufactures, and distributes innovative products and personalized 3D planning tools for hip, knee, shoulder, spine surgery, and sports medicine across global markets including North America, Europe, Asia-Pacific, and emerging regions.

Strategic Profile

Pro stress-test →

Medacta positions itself as an innovation-driven orthopedic player with differentiated 3D surgical planning technology and geographic expansion capabilities. The company leverages acquisitions for market penetration, particularly in sports medicine and the ASC (Ambulatory Surgical Center) segment, supported by medical education investments to drive adoption of its surgical solutions.

Competitive Landscape

Pro stress-test →

Medacta competes in the global orthopedic medical device market dominated by larger players such as Zimmer Biomet, Stryker, and Smith+Nephew. The company differentiates through specialized 3D personalized surgical planning technology and targeted focus on niche segments like sports medicine and ASCs, allowing it to compete despite smaller scale than major multinational competitors.

Industry Context

Medacta Group SA operates in Orthopedic and Neurosurgical Medical Devices.

Key facts

Founded: 1958 · Headquarters: Castel San Pietro, Switzerland · Employees: 1,910 · Revenue: CHF 643.2M (annualized from H2 2025) · Market cap: CHF 3.14B

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on Medacta Group SA.

  • Delivered 18.5% constant-currency revenue growth in 2025, significantly outpacing broader medical device industry trends
  • Market cap of CHF 3.14B with improving profitability (net income up 71.5% to CHF 56.54M in latest half-year)
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • February 2026Reported 18.5% constant-currency revenue growth in 2025 on broad-based demand
  • February 2026Innovation in product launches and medical education expansion driving revenue growth with focus on spine segment and ASCs
  • +1 moreTrack every material event for Medacta Group SA as it happens. Explore monitoring →
Get alerted when Medacta Group SA has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Orthopedic Implants & Surgical SolutionsGlobal leader in musculoskeletal healthcare with comprehensive orthopedic portfolio→Orthopedic & Surgical ProductsMajor medical device company with strong orthopedic and surgical segments→Orthopedic & Trauma SolutionsEstablished player in orthopedic reconstruction and sports medicine→

Compare Medacta Group SA with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Medacta Group SA operates in Orthopedic and Neurosurgical Medical Devices. See how the rest of the sector scores on the Cyborg framework.

Browse Orthopedic and Neurosurgical Medical Devices research →
NEW · MCP server

Ask your AI assistant about Medacta Group SA

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Medacta Group SA and its top competitor on Cyborg Score”
“What did Medacta Group SA do this quarter?”
“Is Medacta Group SA a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com · Terms of Service

Frequently asked questions

What does Medacta Group SA do?+
Medacta Group is a Swiss-based medical device company specializing in orthopedic and neurosurgical solutions. The company designs, manufactures, and distributes innovative products and personalized 3D planning tools f...
What is Medacta Group SA's Cyborg Score?+
Medacta Group SA has a Cyborg Score of 7/10 (Strong). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Medacta Group SA's main competitors?+
Named competitors include Orthopedic Implants & Surgical Solutions, Orthopedic & Surgical Products, Orthopedic & Trauma Solutions. The full competitive landscape is in the AskCyborg report.
How can I get the full Medacta Group SA research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Medacta Group SA research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Medacta Group SA over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.